Evans, SJ; (2016) What Is the Plural of a 'Yellow' Anecdote? Drug safety, 39 (1). pp. 1-3. ISSN 0114-5916 DOI: https://doi.org/10.1007/s40264-015-0368-7 Full text not available from this repository.

Allen, E; Chandler, CI; Mehta, U; Mandimika, N; Pace, C; Bames, KI; (2015) Optimising Methods for Collecting Participant-Reported Safety Endpoints in Antimalarial Drug Clinical Research. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/2344794 Full text not available from this repository.

Evans, SJ; (2015) Is the Yellow Card Road Going in the Right Direction? Drug safety, 38 (6). pp. 517-8. ISSN 0114-5916 DOI: https://doi.org/10.1007/s40264-015-0293-9 Full text not available from this repository.

Evans, SJ; (2013) Moving along the yellow brick (card) road? Drug safety, 36 Sup. pp. 3-4. ISSN 0114-5916 DOI: https://doi.org/10.1007/s40264-013-0096-9 Full text not available from this repository.

Cornelius, VR; Sauzet, O; Evans, SJ; (2012) A Signal Detection Method to Detect Adverse Drug Reactions Using a Parametric Time-to-Event Model in Simulated Cohort Data. Drug safety, 35 (7). pp. 599-610. ISSN 0114-5916 DOI: https://doi.org/10.2165/11599740-000000000-00000 Full text not available from this repository.

Crooks, CJ; Prieto-Merino, D; Evans, SJ; (2012) Identifying adverse events of vaccines using a Bayesian method of medically guided information sharing. Drug safety, 35 (1). pp. 61-78. ISSN 0114-5916 DOI: https://doi.org/10.2165/11596630-000000000-00000 Full text not available from this repository.

Larson, H; Brocard Paterson, P; Erondu, N; (2012) The globalization of risk and risk perception: why we need a new model of risk communication for vaccines. Drug safety, 35 (11). pp. 1053-9. ISSN 0114-5916 DOI: https://doi.org/10.2165/11635880-000000000-00000

Evans, SJ; (2008) Stratification for spontaneous report databases. Drug safety, 31 (11). pp. 1049-52. ISSN 0114-5916 DOI: https://doi.org/10.2165/00002018-200831110-00009 Full text not available from this repository.

Evans, SJW; (2008) Stratification for Spontaneous Report Databases. Drug safety, 31 (11). pp. 1049-1052. ISSN 0114-5916 https://researchonline.lshtm.ac.uk/id/eprint/6036 Full text not available from this repository.

Rodríguez-Pinilla, E; Mejías, C; Prieto-Merino, D; Fernández, P; Martínez-Frías, ML; ECEMC Working Group; (2008) Risk of hypospadias in newborn infants exposed to valproic acid during the first trimester of pregnancy: a case-control study in Spain. Drug safety, 31 (6). pp. 537-43. ISSN 0114-5916 DOI: https://doi.org/10.2165/00002018-200831060-00008 Full text not available from this repository.

Chuang, CH; Doyle, P; Wang, JD; Chang, PJ; Lai, JN; Chen, PC; (2006) Herbal medicines used during the first trimester and major congenital malformations : an analysis of data from a pregnancy cohort study. Drug safety, 29 (6). pp. 537-48. ISSN 0114-5916 DOI: https://doi.org/10.2165/00002018-200629060-00006 Full text not available from this repository.

Dunn, N; Thorogood, M; (2002) Short course in pharmacoepidemiology and pharmacovigilance at the London School of Hygiene and Tropical Medicine. Drug safety, 25 (14). pp. 1045-6. ISSN 0114-5916 DOI: https://doi.org/10.2165/00002018-200225140-00006 Full text not available from this repository.

Bothamley, G; (2001) Drug treatment for tuberculosis during pregnancy: safety considerations. Drug safety, 24 (7). pp. 553-65. ISSN 0114-5916 DOI: https://doi.org/10.2165/00002018-200124070-00006 Full text not available from this repository.